Global Spine Biologics Market 2018-2022

Below are some of the key findings from this spine biologics market analysis report

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

Global spine biologics industry overview

The increase in geriatric population results in a high number of individuals with spine deformities and defects. To overcome these challenges, surgeons use advanced spine biologics mechanisms such as extreme lateral interbody fusion and direct lateral interbody fusion. Moreover, the geriatric population mostly suffers from complications like hypertension, diabetes, and obesity. The advancements in spine biologics make it quite easy for surgeons to treat such patients. As the geriatric population rises globally, the demand for spine biologics increases, thereby leading to the growth of the market.

Increasing cases of lumbar fusion is one of the key trends in the global spine biologics market. Lumbar fusion is a standard procedure performed for the treatment of several degenerative conditions of the spine. Moreover, lumbar fusion also helps to restore stability, reduces deformity, and provides strength to the spine, which increases its adoption among several patients. Spine biologics mechanism are required for the successful lumbar fusion surgery. Thus, the increasing cases of lumbar fusion appear to be favorable for the growth of the spine biologics market, which is projected at a CAGR of more than 4% during the forecast period.

Top spine biologics companies covered in this report

The global spine biologics market is highly fragmented with multiple players occupying the market share. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this spine biologics industry analysis report is designed to help clients identify and build new growth strategies.

The report offers a detailed analysis of several leading spine biologics companies, including:

• Alphatec Spine
• Globus Medical
• Medtronic
• NuVasive

Spine biologics market segmentation based on product

• Bone grafts
• Bone morphogenetic protein (BMP)
• Bone marrow aspirate concentrate (BMAC)
• Others

The bone grafts segment held the largest spine biologics market share in 2017. However, the market share of this segment will decrease in the next five years.

Spine biologics market segmentation based on region

• Americas
• APAC
• EMEA

The Americas accounted for the largest spine biologics market share in 2017. However, this region will witness a decrease in its market share in the next five years.

Key highlights of the global spine biologics market for the forecast years 2018-2022:

• CAGR of the market during the forecast period 2018-2022
• Detailed information on factors that will accelerate the growth of the spine biologics market during the next five years
• Precise estimation of the global spine biologics market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the spine biologics industry across the Americas, APAC, and EMEA
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive details on factors that will challenge the growth of spine biologics companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch